immunity level, infectious respiratory diseases, influenza, nasal flu vaccine, virus

New Nasal Flu Vaccine Significantly Enhances Immunity Level

Many people, especially parents of young children, were relieved when in 2003, the FDA approved FluMist, the first nasal flu vaccine to be marketed in the United States. It is also the first live virus influenza vaccine approved in the U.S. Researchers have hailed nasal flu vaccines for treating infectious respiratory diseases. Nasal flu vaccines tend to fare better than ...

Armin Auctor

Nasal vaccine.